| 25 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.7 |
5mg |
5.1mg |
+1.6% |
98.46% |
Lab A |
| 25 May 2026 |
Liraglutide |
6.5 |
2mg |
1.8mg |
-11.4% |
98.81% |
Lab C |
| 25 May 2026 |
Tren Hex |
7.4 |
100mg/ml |
90.8mg/ml |
-9.2% |
96.09% |
Lab A |
| 24 May 2026 |
Hyaluronic acid |
7.3 |
5mg |
5.4mg |
+8.7% |
98.28% |
Lab E |
| 24 May 2026 |
Lipo-C 120mg |
6.9 |
300mg/ml |
287.3mg/ml |
-4.2% |
97.20% |
Lab C |
| 24 May 2026 |
Livagen |
6.7 |
10mg |
10.2mg |
+2.5% |
99.30% |
Lab E |
| 24 May 2026 |
NAD+ |
7.1 |
2mg |
1.7mg |
-13.1% |
99.77% |
Lab E |
| 24 May 2026 |
Adamax |
6.1 |
50mg |
53.3mg |
+6.6% |
98.38% |
Lab A |
| 24 May 2026 |
NAD+ |
7.3 |
10mg |
11.1mg |
+10.5% |
99.18% |
Lab A |
| 24 May 2026 |
IGF-1 LR3 |
5.2 |
20mg |
23.4mg |
+16.9% |
99.69% |
Lab D |
| 24 May 2026 |
PTD-DBM |
9.6 |
10mg |
10.1mg |
+1.1% |
96.88% |
Lab G |
| 24 May 2026 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
5.5 |
25mg |
25.1mg |
+0.2% |
99.87% |
Lab C |
| 24 May 2026 |
DHB (1-Test Cyp) |
4.6 |
250mg/ml |
214.6mg/ml |
-14.2% |
99.03% |
Lab B |
| 24 May 2026 |
MK-677 (Ibutamoren) Raw |
6.7 |
500g |
556.6g |
+11.3% |
97.03% |
Lab F |
| 24 May 2026 |
RAD-140 (Testolone) Raw |
10.0 |
1g |
1.2g |
+21.7% |
96.44% |
Lab B |
| 24 May 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
7.4 |
5mg |
4.8mg |
-4.2% |
99.15% |
Lab D |
| 24 May 2026 |
Vitamin B12 10mg/ml |
10.0 |
300mg/ml |
311.2mg/ml |
+3.7% |
96.62% |
Lab A |
| 24 May 2026 |
IGF-1 LR3 |
6.6 |
2mg |
1.8mg |
-10.6% |
96.05% |
Lab A |
| 24 May 2026 |
Minoxidil Oral |
4.0 |
100mg |
120.4mg |
+20.4% |
99.03% |
Lab A |
| 24 May 2026 |
Telmisartan |
7.7 |
25mg |
21.4mg |
-14.6% |
99.44% |
Lab E |
| 24 May 2026 |
Tren Hex |
7.6 |
300mg/ml |
357.8mg/ml |
+19.3% |
95.73% |
Lab G |
| 23 May 2026 |
IGF-1 LR3 |
6.4 |
30mg |
30.0mg |
-0.1% |
95.03% |
Lab F |
| 22 May 2026 |
Retatrutide |
9.6 |
30mg |
30.2mg |
+0.7% |
99.74% |
Lab E |
| 21 May 2026 |
Cerebrolysin |
5.9 |
2mg |
2.1mg |
+5.3% |
97.14% |
Lab C |
| 21 May 2026 |
Clenbuterol |
5.3 |
25mg |
25.4mg |
+1.7% |
98.73% |
Lab G |
| 21 May 2026 |
DHB (1-Test Cyp) |
6.9 |
200mg/ml |
238.3mg/ml |
+19.1% |
95.73% |
Lab F |
| 21 May 2026 |
Telmisartan |
6.5 |
10mg |
9.3mg |
-6.7% |
97.61% |
Lab D |
| 20 May 2026 |
Retatrutide |
6.0 |
5mg |
4.6mg |
-8.0% |
99.50% |
Lab G |
| 20 May 2026 |
EPO |
4.0 |
50mg |
59.4mg |
+18.8% |
96.97% |
Lab F |
| 20 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
8.4 |
15mg |
13.9mg |
-7.3% |
95.90% |
Lab F |
| 19 May 2026 |
Cerebrolysin |
6.5 |
50mg |
56.3mg |
+12.5% |
96.43% |
Lab G |
| 19 May 2026 |
Clenbuterol |
7.2 |
100mg |
124.1mg |
+24.1% |
96.63% |
Lab A |
| 19 May 2026 |
Livagen |
4.4 |
20mg |
24.0mg |
+20.1% |
95.24% |
Lab A |
| 19 May 2026 |
Orforglipron |
6.9 |
100mg |
87.6mg |
-12.4% |
95.32% |
Lab A |
| 17 May 2026 |
Cartalax |
4.0 |
5mg |
5.7mg |
+14.9% |
99.68% |
Lab G |
| 17 May 2026 |
MOTS-C |
4.9 |
10mg |
9.4mg |
-6.0% |
96.05% |
Lab B |
| 17 May 2026 |
Tren Hex |
9.3 |
250mg/ml |
286.3mg/ml |
+14.5% |
99.43% |
Lab E |
| 29 Jan 2026 |
AICAR Oral |
4.0 |
100mg |
117.5mg |
+17.5% |
96.41% |
Lab G |
| 29 Jan 2026 |
Anavar (Oxandrolone) |
7.1 |
50mg |
54.3mg |
+8.7% |
98.30% |
Lab F |
| 29 Jan 2026 |
Oxytocin Acetate |
7.4 |
50mg |
61.8mg |
+23.6% |
95.64% |
Lab E |
| 29 Jan 2026 |
Retatrutide 30mg Pen Kit |
4.8 |
2mg |
2.5mg |
+23.5% |
97.55% |
Lab E |
| 26 Jan 2026 |
Anavar (Oxandrolone) |
7.1 |
100mg |
92.2mg |
-7.8% |
99.32% |
Lab E |
| 19 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
4.8 |
10mg |
10.3mg |
+3.0% |
96.17% |
Lab A |
| 19 Jan 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
7.6 |
15mg |
15.9mg |
+6.1% |
97.14% |
Lab B |
| 9 Jan 2026 |
Tirzepatide |
8.4 |
10mg |
8.96mg |
-10.4% |
99.95% |
Lab E |
| 9 Jan 2026 |
ACE-031 |
5.6 |
15mg |
15.1mg |
+0.9% |
97.53% |
Lab E |
| 7 Jan 2026 |
Tirzepatide |
7.5 |
10mg |
10.5mg |
+5.0% |
99.70% |
Lab G |
| 7 Jan 2026 |
Retatrutide |
7.5 |
10mg |
9.7mg |
-3.0% |
99.70% |
Lab G |
| 7 Jan 2026 |
Adamax |
8.8 |
30mg |
26.0mg |
-13.2% |
96.81% |
Lab G |
| 7 Jan 2026 |
Clenbuterol |
7.7 |
50mg |
51.6mg |
+3.1% |
98.28% |
Lab E |
| 7 Jan 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
9.6 |
5mg |
6.1mg |
+22.8% |
97.27% |
Lab G |
| 6 Jan 2026 |
Retatrutide 30mg Pen Kit |
4.4 |
2mg |
2.2mg |
+10.4% |
97.15% |
Lab G |
| 6 Jan 2026 |
Vilon |
7.2 |
10mg |
12.1mg |
+20.8% |
99.36% |
Lab A |
| 1 Jan 2026 |
Tirzepatide |
7.6 |
15mg |
15.8mg |
+5.3% |
99.80% |
Lab G |
| 29 Dec 2025 |
Benzaldehyde CAS 100-52-7 |
4.6 |
5g |
5.6g |
+12.0% |
97.65% |
Lab F |
| 29 Dec 2025 |
TrenMix 200 |
5.4 |
250mg/ml |
299.6mg/ml |
+19.8% |
96.15% |
Lab C |
| 16 Dec 2025 |
Retatrutide |
9.5 |
10mg |
10.3mg |
+3.0% |
99.70% |
Lab G |
| 12 Dec 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.2 |
10mg |
8.5mg |
-14.8% |
99.17% |
Lab C |
| 23 Nov 2025 |
Anavar (Oxandrolone) |
6.8 |
10mg |
12.4mg |
+23.8% |
96.18% |
Lab F |
| 23 Nov 2025 |
Drostanolone Propionate (Mast P) Raw |
6.8 |
5g |
4.9g |
-2.9% |
95.45% |
Lab E |
| 23 Nov 2025 |
Liraglutide |
5.1 |
20mg |
24.8mg |
+23.8% |
98.85% |
Lab G |
| 17 Nov 2025 |
ACE-031 |
4.8 |
5mg |
4.4mg |
-11.3% |
95.49% |
Lab C |
| 17 Nov 2025 |
Orforglipron |
9.4 |
50mg |
42.6mg |
-14.7% |
95.21% |
Lab C |
| 17 Nov 2025 |
TrenMix 200 |
5.2 |
300mg/ml |
372.9mg/ml |
+24.3% |
96.75% |
Lab G |
| 14 Nov 2025 |
P21 |
8.9 |
15mg |
16.8mg |
+11.7% |
97.76% |
Lab E |
| 5 Nov 2025 |
PTD-DBM |
7.0 |
10mg |
12.0mg |
+20.0% |
97.41% |
Lab F |
| 4 Nov 2025 |
Test Suspension |
6.5 |
300mg/ml |
280.9mg/ml |
-6.4% |
97.49% |
Lab F |
| 17 Oct 2025 |
ACE-031 |
5.8 |
10mg |
10.9mg |
+9.0% |
96.51% |
Lab A |
| 9 Oct 2025 |
Livagen |
4.4 |
20mg |
20.7mg |
+3.4% |
95.24% |
Lab A |
| 3 Oct 2025 |
CJC-1295 With DAC |
6.9 |
30mg |
29.3mg |
-2.2% |
96.45% |
Lab E |
| 3 Oct 2025 |
PTD-DBM |
6.2 |
2mg |
1.9mg |
-3.0% |
98.92% |
Lab D |
| 3 Oct 2025 |
TrenMix 200 |
7.5 |
300mg/ml |
352.6mg/ml |
+17.5% |
96.98% |
Lab F |